(Total Views: 548)
Posted On: 02/22/2020 7:52:14 PM
Post# of 149288
I just looked up the cost of Keytruda - $150,000 a year. Medicare usually does not cover Keytruda, possibly because it's an adjuvant therapy? Keytruda is also an IV drug. Then there's the side effects.
Leronlimab as a cancer monotherapy drug would be $60,000. As an outpatient drug and not adjuvant should be covered by Medicare. Self injectable and completely safe.
Humira is the best selling drug currently. Humira costs $38,000 a year. Humira MOA is that it binds to TNF alpha reducing inflammation. Serious side effects including potentially cancer.
One of the main modes of action with leronlimab is anti-inflammation it does this by among other things limiting macrophage recruitment which covers a broader spectrum of patients then just those with overactive TNF alpha production.
Take into account that anyone taking leronlimab for cancer or as an anti-inflammatory will reduce their chances of heart disease, parkinson's, alzheimer's and getting HIV.
We can take down the number 1 drug, the number 2 drug and so much more.
Leronlimab as a cancer monotherapy drug would be $60,000. As an outpatient drug and not adjuvant should be covered by Medicare. Self injectable and completely safe.
Humira is the best selling drug currently. Humira costs $38,000 a year. Humira MOA is that it binds to TNF alpha reducing inflammation. Serious side effects including potentially cancer.
One of the main modes of action with leronlimab is anti-inflammation it does this by among other things limiting macrophage recruitment which covers a broader spectrum of patients then just those with overactive TNF alpha production.
Take into account that anyone taking leronlimab for cancer or as an anti-inflammatory will reduce their chances of heart disease, parkinson's, alzheimer's and getting HIV.
We can take down the number 1 drug, the number 2 drug and so much more.
(7)
(0)Scroll down for more posts ▼
